| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $335.4M | +10.3% |
| Cost of Revenue | $318.1M | +22.5% |
| Gross Profit | $17.3M | -61.1% |
| R&D Expense | $19.8M | +222.5% |
| SG&A Expense | $171.3M | +139.9% |
| Operating Income | -$229.7M | -444.3% |
| Interest Expense | $39.8M | +194.9% |
| Pre-tax Income | -$251.6M | -116.3% |
| Income Tax | -$25.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $94.5M | +180.2% |
| Accounts Receivable | $37.3M | +70.1% |
| Inventory | $55.8M | +2394.3% |
| Current Assets | $252.8M | +100.8% |
| Total Assets | $1.45B | +395.2% |
| Current Liabilities | $155.6M | +4.2% |
| Long-term Debt | $85.2M | -32.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$177.3M | -922.2% |
| Capital Expenditures | $13.5M | +110.6% |
| Investing Cash Flow | -$175.1M | -2331.9% |
| Financing Cash Flow | $397.5M | +809.3% |
| Free Cash Flow | -$190.8M | -703.5% |
| -1138.3% |
| Net Income | -$226.6M | -98.2% |
| EPS (Basic) | -$2.28 | +3.0% |
| EPS (Diluted) | -$2.28 | +3.0% |
| Total Liabilities |
| $312.1M |
| -9.4% |
| Stockholders' Equity | $1.06B | +661.7% |